Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Ruzasvir has demonstrated highly potent and pan-genotypic antiviral activity in preclinical (picomolar range) and clinical studies. Ruzasvir has been administered to over 2,100 subjects at daily doses ...

Company Hosting Virtual KOL Panel Event Thursday, November 13th at 10:00 AM ETBOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Atea ...

An area called the central Southern Cone in South America, which consists of a large part of Argentina, is known to be one of ...

Sionna Therapeutics, Inc. ( ($SION) ) has released its Q3 earnings. Here is a breakdown of the information Sionna Therapeutics, Inc. presented to ...

Inside every cell, a finely tuned metabolic network determines when to build, recycle, or stop producing essential molecules.

Researchers analyzed the role of NUDT5 and its interaction with other proteins in the folate pathway and in regulating purine synthesis.

Discover why Sionna Therapeutics stock may offer upside, driven by a strong cash position and key cystic fibrosis clinical ...

With more than 250 peer-reviewed papers published in several high-impact journals, Katalin Susztak, MD, PhD, has opened the ...

Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...

Received CTA authorization for Phase 1 trial of lead program AX-0810, targeting NTCP for cholestatic diseasesInitiating Phase ...